+35.4%
CVS vs NCLH
-38.5%
+74.0%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NCLH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -0.1% | -0.3% | -0.5% |
| 7D | +4.0% | -6.5% | +10.4% | +4.2% |
| 30D | -2.4% | -23.3% | +20.9% | -1.4% |
| 3M | +2.7% | -18.6% | +21.3% | +3.4% |
| 6M | +21.9% | -26.2% | +48.1% | +23.1% |
| YTD | +24.7% | -30.2% | +55.0% | +25.7% |
| 1Y | +35.4% | -39.2% | +74.6% | +44.1% |
| All | +35.4% | -38.5% | +74.0% | +44.1% |
Cumulative growth
Daily Returns
Daily percentage return beside NCLH.
Daily Out/Under-Performance
Portfolio return minus NCLH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NCLH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NCLH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling